Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -0.33% | -1.61% | +51.49% |
10/05 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
08/05 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.49% | 28Cr | |
+38.51% | 73TCr | |
+33.05% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 20TCr | |
-5.77% | 20TCr | |
+6.19% | 16TCr |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Transcript : Aquestive Therapeutics, Inc., 2021 Earnings Call, Mar 09, 2022